MAPT and Alzheimer disease: In P301L/S tauopathy models, tau aggregation is driven by progressive phosphorylation within the proline-rich domain and the C-terminus, while ubiquitination and acetylation, characteristics of early-stage AD in humans, are not represented in this mouse model [235].